Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis

E Zonneveld‐Huijssoon, A Ronaghy… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To determine whether vaccinations aggravate the course of autoimmune diseases
such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations …

Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study

SP Stoof, MW Heijstek, KM Sijssens… - Annals of the …, 2014 - ard.bmj.com
Objectives The kinetics of the antibody response induced by meningococcal serogroup C
(MenC) conjugate vaccination was analysed in patients with juvenile idiopathic arthritis (JIA) …

Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective …

M Ohm, JW van Straalen, M Zijlstra, G de Joode-Smink… - Vaccine, 2023 - Elsevier
Background Immunogenicity to meningococcal serogroup ACWY (MenACWY) conjugate
vaccine has not been studied in immunocompromised minors with juvenile idiopathic …

Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis

A Ronaghy, W de Jager… - Annals of the …, 2011 - ard.bmj.com
Objective To investigate how meningococcal C vaccination in patients with remitting
(oligoarticular) or progressive (polyarticular) juvenile idiopathic arthritis (JIA) influences the …

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis

NE Aikawa, LMA Campos… - Scandinavian Journal …, 2013 - Taylor & Francis
Objectives: To assess the vaccine response in juvenile idiopathic arthritis (JIA) as an
extension of previous observation of immunogenicity and safety of a non-adjuvanted …

Vaccinations in juvenile chronic inflammatory diseases: an update

CA Silva, NE Aikawa, E Bonfa - Nature Reviews Rheumatology, 2013 - nature.com
Vaccination is a powerful tool to reduce the burden of infectious diseases in paediatric
patients with chronic rheumatic diseases. Live attenuated vaccines are not recommended …

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay

MS Camacho-Lovillo, A Bulnes-Ramos… - Pediatric …, 2017 - Springer
Background Seasonal influenza virus vaccination should be considered in all pediatric
patients with rheumatic diseases. Few studies have addressed influenza vaccination safety …

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease

AJ Pollard, C Green, M Sadarangani… - Archives of disease in …, 2013 - adc.bmj.com
The serogroup C meningococcal immunisation programme was reviewed during 2012 by
the Department of Health's Joint Committee on Vaccination and Immunisation (JCVI), and an …

Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis

MW Heijstek, GCS Pileggi… - Annals of the …, 2007 - ard.bmj.com
Objective: To assess the effect of measles, mumps and rubella (MMR) vaccination on
disease activity in children with juvenile idiopathic arthritis (JIA). Methods: A retrospective …

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis

E Farmaki, F Kanakoudi-Tsakalidou, V Spoulou… - Vaccine, 2010 - Elsevier
Our aim was to study the effect of anti-TNF treatment on immunogenicity and safety of the 7-
valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Thirty …